Abstract
The most significant achievements in the cardiovascular research areas have been reviewed. Among the beta-adrenoceptor blockers, antihypertensive, positive inotropic, and antiarrhythmic compounds synthesized and investigated at the IDR, a number of new drug candidates have been found and studied in clinical phases. One compound has been marketed (Tobanum, beta-adrenoceptor blocker).
MeSH terms
-
Academies and Institutes
-
Adrenergic beta-Antagonists / chemical synthesis
-
Anti-Arrhythmia Agents / chemical synthesis
-
Antihypertensive Agents / chemical synthesis
-
Cardiotonic Agents / chemical synthesis
-
Cardiovascular Agents / chemical synthesis*
-
Cardiovascular Agents / chemistry
-
Drug Industry / trends
-
Hungary
-
Molecular Structure
-
Research / trends
Substances
-
Adrenergic beta-Antagonists
-
Anti-Arrhythmia Agents
-
Antihypertensive Agents
-
Cardiotonic Agents
-
Cardiovascular Agents